An interventional study of total knee arthroplasty with medial pivot tibial insert or symmetrical insert in Knee Osteoarthritis, sponsored by Elda University Hospital. Recruiting at 1 site in Spain. Open to participants aged 50 Years to 99 Years. Per ClinicalTrials.gov, last updated 2022-04-07.
Sponsored by Elda University Hospital · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 100 studies in Osteoarthritis, Knee with a site in Spain — 16 open to participants now, 19 under way, 3 of them phase 3. Osteoarthritis, Knee · Spain.
Among the 100 studies in Osteoarthritis, Knee with a site in Spain, this one is the 42nd largest by planned enrollment of the 86 interventional ones that give a count, is one of 9 that started in 2022, is one of 47 with no phase, reaches primary completion later than 4 of the 18 other live ones, and was the 62nd registered.
3,297 studies on the registry are indexed under Osteoarthritis, Knee; 623 are open to participants now.
Browse Osteoarthritis, Knee studies →16 of the 100 studies in Osteoarthritis, Knee with a site in Spain are open now. Recruiting first, the newest first:
Universidad Católica San Antonio de Murcia · Sites in Spain
Ages 31+
Universidad Complutense de Madrid · Sites in Spain
Ages 45+
Novo Nordisk A/S · Sites in Spain, United States, Australia and 8 more countries
Ages 18+
Novo Nordisk A/S · Sites in Spain, United States, Australia and 7 more countries
Ages 18+
University of Valencia · Sites in Spain
Ages 50–85
A study can be open while its sites in Spain have not opened yet or have stopped. Only those recruiting at a site in Spain →
Of the 384 Osteoarthritis, Knee studies recruiting now, 178 (46%) set no upper age limit and 113 (29%) stop at 75 or younger; 19 take children under 18; 39 take healthy volunteers.
This study: 50 Years to 99 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
100 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 5 · Phase 2 15 · Phase 3 16 · Phase 4 8
First in 2000; this study’s year is marked. 9 started in 2022.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 100 is above the median of 68 across 2,719 interventional studies indexed under Osteoarthritis, Knee.
Median enrollment 100 across the 86 interventional studies, 153 across the 14 observational. Of the 71 that completed or were terminated, 19 (27%) have results posted.
This tab as a report to print or save as PDF → With an account.
43 of 100 have an industry lead sponsor. The 10 most frequent:
Elda University Hospital is the lead sponsor of 3 studies on the registry; 2 are open to participants now.
Elda University Hospital has 1 study filed under Osteoarthritis, Knee — fewer than ten, so there is no comparison to draw.
4 of the studies in Osteoarthritis, Knee with a site in Spain that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT06721897University of JaénEffectiveness of a Prehabilitation Program for Hip or Knee Arthroplasty Surgery. | 2026-11-30 |
| NCT07434011Universidad Complutense de MadridEfficacy of Artificial Intelligence-Assisted Therapeutic Exercise in Patients With Knee Osteoarthritis | 2027-03-15 |
| NCT07886697Universidad Rey Juan CarlosLow-Dose Radiotherapy for Painful Knee Osteoarthritis | 2027-06-30 |
| NCT07870967Universidad Católica San Antonio de MurciaUndenatured Type II Collagen for Knee Osteoarthritis Pain | 2027-07 |
Add all 4 to your calendar (.ics) → With an account.
Among the 100 studies in Osteoarthritis, Knee with a site in Spain, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The functional outcome and longevity of total knee arthroplasty (TKA) is still a concern. Despite various developments in TKA designs, including fixed or mobile bearing, cruciate retaining or posterior stabilized, multi or single radius, it remains unclear which design is superior for achieving a physiological kinematic.
In normal healthy knees the medial and lateral tibial condyles are different: the medial is almost flat while the lateral is somewhat convex. Thus, the movement during flexion is asymmetric: during the flexion, the medial condyle is stable throughout the range of motion while the lateral condyle slides anteroposteriorly with respect to femur). Therefore, the native knee requires a specific degree of rollback of the lateral compartment coupled with a medial pivot, which leads to an external axial rotation of the femur. This rollback is thought to be even more pronounced with increasing knee flexion angles to enable deep flexion without excessive shear forces acting at the patella or overloading the extensor mechanism.
In addition, stability throughout flexion is a crucial element to normal knee function. Most TKA designs removal of the ACL, and the PCL in posterior-stabilized design, but the TKA do not fully restore the function of those ligaments.
Based on this philosophy, the medial pivot TKA was designed to provide better function, patient satisfaction and increased survival.
The objective of this study is to analyze whether the medial pivot design provides better outcome and prosthesis survival than conventional total knee arthroplasty.
Candidates for the study will be consecutive patients eligible for total knee arthroplasty (TKA) at our center. All patients meeting inclusion criteria will be recruited for enrollment into the study. Informed consent will be obtained from the patient prior to randomization.
At that time, each patient will be randomized into one of two groups by an independent staff using computer generated randomization and allocation concealment. The two patient groups will include:
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Device used: medial pivot total knee arthroplasty design
Device: total knee arthroplasty with medial pivot tibial insert or symmetrical insert
Device used: conventional total knee arthroplasty design
Device: total knee arthroplasty with medial pivot tibial insert or symmetrical insert
standard surgical implantation of total knee arthroplasty
The Knee Society Score
Functional KSS score (range 0-100) with higher scores as better outcome. A good result is defined as 70 points or greater
Time frame: 2 years
Plan to share: Yes — IPD that underlie results in a publication
Supporting information: Study protocol
Time frame: 6 months after publication
Access criteria: Request to the principal investigator
No publications or documents are linked to this record.
Started Jan 2022 (actual). Primary completion is estimated for Dec 2024, 35 months after the start.
Of 1,114 non-industry interventional studies with no phase under Osteoarthritis, Knee, half reached primary completion within 18 months of starting (the median), counting those still running; a quarter within 8 and three quarters within 36. This study's planned 35 months is above that.
Counting every sponsor, half of 1,253 studies reached it within 18 months; a quarter within 8 and three quarters within 36.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Elda University Hospital